RecruitingNCT04873258

Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease

Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in Volunteers on Clinical Trials Utilising Machine-learning and Bioimpedance Vector Analysis

Sponsor

Richmond Research Institute

Enrollment

2,000 participants

Start Date

Sep 27, 2019

Study Type

OBSERVATIONAL

Conditions

Healthy MASLD Obesity and Obesity-related Medical Conditions Fatty Liver MASLD - Metabolic Dysfunction-Associated Steatotic Liver Disease

Summary

A generic screening study to establish structural and/or functional baselines of specific organs.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Bioimpedence Vector Analysis for people with fatty liver, healthy, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.